Back to Journals » Biologics: Targets and Therapy » Volume 13
Original Research
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,714 | Dovepress* | 9,835+ | 1,870 | 11,705 | |
PubMed Central* | 879 | 356 | 1,235 | ||
Totals | 10,714 | 2,226 | 12,940 | ||
*Since 3 January 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
9 | 0 | 0 | 0 | 1 | 8 |
View citations on PubMed Central and Google Scholar